Matrix Advanced Solutions
Peptide Dosing Guide
GH Secretagogue

Ipamorelin

Stimulates pituitary GH release via ghrelin/GHS-R1a receptor — cleaner profile with no hunger or cortisol spikes.

VIAL IMAGE NEEDED

What It Is

A growth hormone secretagogue that stimulates your body to release more of its own GH. One of the cleaner peptides — doesn't spike hunger or cortisol like GHRP-6. Used for recovery, fat loss support, and anti-aging.

Mechanism of Action

Ipamorelin acts on the ghrelin/GHS-R1a receptor in the pituitary gland, stimulating the release of endogenous growth hormone. Unlike older GH secretagogues such as GHRP-6, it has a cleaner profile — it does not significantly increase hunger, cortisol, or prolactin levels, making it one of the most selective GHS peptides available.

Key Benefits

Improved sleep quality
Enhanced recovery
Subtle fat loss support
IGF-1 elevation
Anti-aging support

Dosing Protocol

Tier Dose Frequency Notes
Starting 200 mcg Daily (bedtime) Begin here to assess tolerance
Moderate 300 mcg Daily Standard protocol dose
High 500 mcg Daily Advanced — monitor IGF-1

Cycle Length: 8–12 weeks

Timing: Before bed or fasted

Route: Subcutaneous injection

Must be fasted — insulin suppresses GH release. Do not inject after eating.

Administration & Reconstitution

Recommended Stacks

How To Know It's Working

Protocol Notes & Common Mistakes

Safety & Side Effects

Possible side effects:
  • Mild water retention or bloating
  • Injection site redness
  • Possible headaches at high doses

Ipamorelin has a clean side-effect profile compared to older GHS peptides (GHRP-2, GHRP-6). However, long-term data remains limited.

Monitoring: IGF-1 at 6 weeks is the primary safety and efficacy marker. If IGF-1 is elevated above range, reduce dose or pause the protocol.